Skip to content
Clinical Research Society

Clinical Research Society

International Society for Clinical Research and Translational Medicine

  • About Us
    • Executive Council
    • Committees
    • President’s Message
    • Code of Ethics
    • Our Logo
  • Membership
    • Professional Membership
    • Associate Membership
    • Student Membership
    • Institutional Membership
    • Membership Renewal
  • Training & Certification
    • GCP Certification
    • CRA Certification
    • CRC Certification
    • Emerging Clinical Research Professional
    • Project Management Certification
    • Training Demo
    • Register for Certification Exam
  • Careers
  • Contact

Chemotherapy

Clinical Research / Pharma News 

Nivolumab Can Increase Survival Rate in Head and Neck Cancer Patients

Checkpoint inhibitors, Chemotherapy, Drug resistance

Advanced head and neck cancer that is resistant to chemotherapy is highly difficult to treat.  However, an immunotherapy drug called

Read more
Clinical Research / Pharma News 

Pancreatic Cancer: FAK Inhibitors to Chemotherapy and Immunotherapy might Increase Survival Rate

Chemotherapy, Combination, focal adhesion kinase inhibitor, Immunotherapy

Pancreatic cancer is among the challenging cancers to treat; tumors of the pancreas usually do not react to present treatments.

Read more
Clinical Research / Pharma News 

Novel Method to Foresee Chemo-induced Heart Failure

Chemotherapy, Identification, Muscle damage

A small number of patients treated with a common chemotherapy medicine, doxorubicin, develop serious heart damage, but there is presently

Read more

Example Widget

This is an example widget to show how the Right Sidebar looks by default. You can add custom widgets from the widgets screen in the admin. If custom widgets are added then this will be replaced by those widgets.

Copyright © 2023 Clinical Research Society. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.

Offer the visitors your services or goods.

Describe what they will receive and how they will benefit from it.

Do not forget a coaxing call to action, but also a way to decline.
Put the final call to action.

  • Yes I want it!
  • No thank you!